The QRSL1 gene helps mitochondria, the parts of cells that make energy, build a small but essential set of proteins. This gene plays an important role in keeping that energy-making process running properly. If the QRSL1 gene does not work well, cells may struggle to produce enough energy, especially in high-need organs such as the heart, brain, and liver. Rare harmful variants in this gene are linked to an inherited mitochondrial condition that can cause severe symptoms early in life.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or for directing processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this subject in more detail, you can learn more in the LearnHub.
Overview
QRSL1Gene function
What if the gene works
The QRSL1 gene helps mitochondria, your cells’ energy makers, build certain proteins. This supports normal energy production, especially in tissues like the heart, brain, and muscles.
Risk
What if the gene does not work
Changes in the QRSL1 gene can disrupt mitochondrial energy production, often leading to early problems with movement, development, and heart function. Effects can range from milder to more severe, influencing when symptoms start and how strongly they affect someone.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the QRSL1 gene, no QRSL1-specific treatment or drug-selection approach is currently established. Care is based on the person’s symptoms and general mitochondrial disease management, not on a QRSL1-targeted medicine.
Conditions associated with QRSL1
Gene function
What if the gene works
Inside mitochondria, your cells need a precise way to make a small set of proteins that help release energy from food. The QRSL1 gene supports that process by helping prepare one of the helper molecules used during protein building. When this step runs smoothly, mitochondrial protein production stays accurate and efficient.
One of the roles of the QRSL1 gene is to prepare transfer RNA (a small helper molecule used in protein making) inside mitochondria. It helps convert an attached amino acid into the correct one, so the next protein building step can move forward accurately.
This preparation step is needed for mitochondrial protein synthesis, which is how mitochondria make some of their own proteins. With the correct helper molecule in place, those protein instructions can be read as intended.
By supporting protein production inside mitochondria, the QRSL1 gene helps cells maintain the machinery they use to make energy. This keeps routine cell activity running in tissues that rely on a steady energy supply.
What is a variant?
A genetic variant is a minor alteration in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the QRSL1 gene can weaken or disrupt a mitochondrial step that helps cells build proteins needed for energy. Some changes alter the protein's shape or stability, while more disruptive variants can stop it from joining partner proteins and sharply reduce enzyme activity. This helps explain how QRSL1 gene variants affect mitochondrial protein synthesis: milder variants may leave some function, whereas severe loss-of-function variants can cause a larger energy shortfall and are often linked to earlier, more severe disease.
How variants are linked to conditions
Pathogenic variants in the QRSL1 gene cause combined oxidative phosphorylation deficiency 40, a rare inherited mitochondrial condition. In reports on QRSL1 gene variants linked to disease, affected infants or children may have low muscle tone, feeding problems, developmental delay, high lactate levels, seizures, or heart involvement such as hypertrophic cardiomyopathy. This diagnosis is typically confirmed when disease-causing variants are found in both copies of the QRSL1 gene.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not directly affect health and instead represent normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a part. In some situations, however, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to the QRSL1 gene. For families with a disease-causing QRSL1 change, risk is mainly tied to the inherited gene change rather than everyday lifestyle factors, and a doctor or genetic counselor can explain personal and family risk.
Inheritance of QRSL1 variants
QRSL1-related conditions are inherited in an autosomal recessive pattern. This means a person usually develops the condition only if they inherit two disease-causing QRSL1 gene variants, one from each parent. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is also a carrier, and a 25% chance of having a child with neither variant. In practical terms, the inheritance of QRSL1 gene variants can affect sons and daughters equally.
What does my QRSL1 result mean for my family?
For families with a disease-causing QRSL1 result, the pattern is usually recessive, which means parents are often healthy carriers and brothers or sisters may also be carriers or, less often, have the same condition. Close relatives may want to learn whether the same change runs in the family, especially if there is a history of similar symptoms or affected children.
Genetic information
Genetic testing
How you find out about variants
QRSL1 genetic testing usually uses a blood sample, saliva, or a cheek swab to read the DNA code and look for variants in the QRSL1 gene. This can be done as single-gene testing or as part of a broader mitochondrial disease panel or exome test. Results show whether a variant was found and how strongly it is linked to disease.
When should I consider getting a genetic test?
QRSL1 testing may be considered if a baby or child has signs of a rare inherited energy condition, such as severe weakness, feeding problems, seizures, or heart problems, especially with a family history. It can also help with carrier testing or pregnancy planning when a QRSL1 variant is already known in the family.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains depends on the condition and the kind of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information gives context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results may also help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because each body absorbs, breaks down, and uses drugs a little differently. These differences are common and can influence how strongly a medicine acts or how sensitive someone is to it. Medication response also depends on other factors, including age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can shape the way a person responds to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can help support more informed, more individualized treatment decisions. You can explore this topic further in the LearnHub.
Drugs influenced by the QRSL1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. If you have side effects, poor symptom control, or questions about any medicine or supplement, talk with your doctor or pharmacist.